Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Blood Virus Testing Market: By Test Type, By Virus Type, By End User and Geography
Blood Virus Testing Market: By Test Type, By Virus Type, By End User and Geography
Blood Virus Testing Market was valued at US$ 19,201.3 million in 2023 and is poised to grow at a CAGR of 6.4% from 2024 to 2030. Blood virus testing is a process of detecting viruses in blood samples. blood virus testing helps in identifying the virus-causing infection and to determine best treatment. Blood virus is useful in early detection of infections which can improve treatment outcomes. Increasing prevalence of blood borne viral infection such as hepatitis-B, C, HIV is expected to drive the blood virus testing market growth. The increasing incidence of viral infections are expected to increase the demand for accurate and reliable diagnostic tests to diagnose in early stages. In addition, increasing demand for blood and blood-derived products which are used for transfusion surgeries, and other medical procedures is expected to boost the growth of blood virus testing market as it is necessary to test for blood borne viral infections to prevent the transmission of viral infections.
Furthermore, the advancement in diagnostics and the development of new diagnostic tools and techniques such as nucleic acid testing and other diagnostic tests to improve the accuracy and timeliness of blood virus testing is expected to boost the growth of virus testing market at a significant rate over the forecast period. However, high cost associated with blood virus testing in developing countries along with limitation for current diagnostic technologies, especially in patients with low viral load and patients co-affected with multiple infection are expected to restraint the growth of blood virus testing market. Moreover, the growing focus on preventive healthcare and rising use of blood tests for early detection along with the technological advancement and innovation in diagnostics are anticipated to provide an opportunity to the market key players in the growth of blood virus testing market over the forecast period.
Study Period
2024-2030Base Year
2023CAGR
6.4%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The blood virus testing market is expected to grow over the forecasted period due to the increasing prevalence of blood borne viral infections such as HIV, Hepatitis-C, B. these infections are transmitted through contaminated blood, body fluids, and tissues. Early diagnosis and treatment of viral infection are crucial to prevent transmission and disease progression. For instance, according to the World Health Organization, about 325 million people globally were living with hepatitis B and C in 2019. The rising burden of blood borne viral infection is expected to increase the demand for blood virus testing across the globe and drive the growth of blood virus testing market over the forecast period.
The blood virus testing market is segmented based on regions into North America, Asia-pacific, Europe, Latin America, and the Middle East and Africa. The North America blood virus testing market is likely to hold a significant revenue share, and in the forecasted years, it is predicted to increase rapidly due to the presence of well-established healthcare infrastructure and increasing awareness among the people about the infection and treatment. Asia Pacific region is expected to be fastest growing region and expected to have highest CAGR over the forecast period owing to rising incidence of blood borne viral infections along with the improving healthcare infrastructures in developing countries like China, India, Japan.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 19,201.3 million |
|
Market CAGR |
6.4% |
|
By Virus Type |
|
|
By Test Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
High cost of blood testing is expected to hinder the growth of blood virus testing market over the forecast period.
The leading players in the global Blood Virus Testing market are BioMérieux, Bio-Rad Laboratories, Abbott, Randox Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Omega Diagnostics Group, OraSure Technologies.
The Blood Virus Testing market is segmented based on Virus Type, Test Type, End User, and geography.
| 1.Executive Summary |
| 2.Global Blood Virus Testing Market Introduction |
| 2.1.Global Blood Virus Testing Market - Taxonomy |
| 2.2.Global Blood Virus Testing Market - Definitions |
| 2.2.1.Test Type |
| 2.2.2.Virus Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Blood Virus Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Blood Virus Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Blood Virus Testing Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Hepatitis viruses |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Human Immunodeficiency Virus |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Human T-Lymphotropic Virus |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Blood Virus Testing Market By Virus Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Full Blood Count Test |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Test for Inflammation |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Immunology Test |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Liver Function Test |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Blood Virus Testing Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Centers |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Clinics |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Ambulatory Surgical Centers |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Blood Virus Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Blood Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hepatitis viruses |
| 9.1.2.Human Immunodeficiency Virus |
| 9.1.3.Human T-Lymphotropic Virus |
| 9.1.4.Others |
| 9.2. Virus Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Full Blood Count Test |
| 9.2.2.Test for Inflammation |
| 9.2.3.Immunology Test |
| 9.2.4.Liver Function Test |
| 9.2.5.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic Centers |
| 9.3.3.Clinics |
| 9.3.4.Ambulatory Surgical Centers |
| 9.3.5.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Blood Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hepatitis viruses |
| 10.1.2.Human Immunodeficiency Virus |
| 10.1.3.Human T-Lymphotropic Virus |
| 10.1.4.Others |
| 10.2. Virus Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Full Blood Count Test |
| 10.2.2.Test for Inflammation |
| 10.2.3.Immunology Test |
| 10.2.4.Liver Function Test |
| 10.2.5.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic Centers |
| 10.3.3.Clinics |
| 10.3.4.Ambulatory Surgical Centers |
| 10.3.5.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Blood Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hepatitis viruses |
| 11.1.2.Human Immunodeficiency Virus |
| 11.1.3.Human T-Lymphotropic Virus |
| 11.1.4.Others |
| 11.2. Virus Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Full Blood Count Test |
| 11.2.2.Test for Inflammation |
| 11.2.3.Immunology Test |
| 11.2.4.Liver Function Test |
| 11.2.5.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic Centers |
| 11.3.3.Clinics |
| 11.3.4.Ambulatory Surgical Centers |
| 11.3.5.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Blood Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hepatitis viruses |
| 12.1.2.Human Immunodeficiency Virus |
| 12.1.3.Human T-Lymphotropic Virus |
| 12.1.4.Others |
| 12.2. Virus Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Full Blood Count Test |
| 12.2.2.Test for Inflammation |
| 12.2.3.Immunology Test |
| 12.2.4.Liver Function Test |
| 12.2.5.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic Centers |
| 12.3.3.Clinics |
| 12.3.4.Ambulatory Surgical Centers |
| 12.3.5.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Blood Virus Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Hepatitis viruses |
| 13.1.2.Human Immunodeficiency Virus |
| 13.1.3.Human T-Lymphotropic Virus |
| 13.1.4.Others |
| 13.2. Virus Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Full Blood Count Test |
| 13.2.2.Test for Inflammation |
| 13.2.3.Immunology Test |
| 13.2.4.Liver Function Test |
| 13.2.5.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic Centers |
| 13.3.3.Clinics |
| 13.3.4.Ambulatory Surgical Centers |
| 13.3.5.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.BioMérieux |
| 14.2.2.Bio-Rad Laboratories |
| 14.2.3.Abbott |
| 14.2.4.Randox Laboratories |
| 14.2.5.F. Hoffmann-La Roche |
| 14.2.6.Thermo Fisher Scientific |
| 14.2.7.Omega Diagnostics Group |
| 14.2.8.OraSure Technologies |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.